Menarini Korea is expected to distribute Viagra

Menarini seems to have chosen Viagra as a follow-up to the end of Arcoxia sales rights

Jeil Pharmaceutical, which was in charge of sales, terminated its contract with Viatris Korea

Viagra, which was sold by Jeil, is likely to be distributed at Menarini from next month.

 

According to the pharmaceutical industry on the 12th, Menarini is in charge of distributing urological treatments such as Viatris Korea's Viagra, Cadura, and Detrusitol.

 

The move follows the termination of Viatris and Jeil's sales rights contract for these products.

 

In addition to Viatris Korea and Viagra, Jeil has been conducting joint promotions of Lipitor Plus, and it is known that the promotion of Lipitor Plus is maintained.

 

Medications that stop distribution through Jeil are 50 mg of Viagra tablet, 100 mg of Viagra L film, 100 mg of Viagra L film, 100 mg of Detrusitol SR 2 mg, 4 mg of Detrusitol SR, and 4 mg of Cadura XL.

 

The date of discontinuation of distribution is December 23rd.

 

There is a rumor in the industry that Viatris Korea has already decided on its next partner.

 

Menarini is said to be the most likely related company.

 

Prior to this, Menarini recently announced to trading drug distributors that it would change the OX-2 inhibitor Arcoxia 30mg seller.

 

Organon Korea will take over Arcoxia's sales rights.

 

Arcoxia was sold by Menarini under a global partnership agreement after MSD ended its green cross and co-marketing in 2018.

 

In the industry, some analysts say that Viatris Korea's right to sell urology-related treatments such as Viagra may have been chosen as a follow-up measure following Nemarini's termination of Arcoxia sales rights.

 

An official from the distribution industry said, "Viatris Korea has Menarini in mind as Jeil's next partner, and I know that only the final decision is left," adding, "It is expected to be a measure following the end of Arcoxia sales rights." 정품 비아그라 https://xoad79.com